SEC Form 4 · accession 0001628908-26-000049
Evolent Health, Inc. · EVH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard M Jelinek
Director
Period of report
Jun 4, 2026
Accepted (ET)
Jun 8, 2026 · 4:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001628908
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jun 4, 2026 | A | 41,096 | $0.00 | A | 77,533 | D | |
| Class A Common Stock | holding | — | — | — | 15,000 | I | By the Richard M Jelinek Revocable Trust | |
| Class A Common Stock | holding | — | — | — | 15,000 | I | By the Richard M Jelinek GST |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
- F2Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.